Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced new findings from its latest pre ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

After Sinovac Biotech and AstraZeneca ... Get updates on your preferred social platform Follow us for the latest news, insider access to events and more.

Get your company published in the world ... latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next. Start listening today!

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

These are the ... for biotechnology and applied microbiology. Read the methodology » To unlock more data and access tools to help you get into your dream school, sign up for the U.S. News ...

Shares of NYSE:ABBV traded down $2.61 during trading hours on Monday, reaching $170.38. The stock had a trading volume of 1,988,237 shares, compared to its average volume of 5,989,680. AbbVie has ...

The cyclical, high-risk, high-reward nature of the biotech industry is on full display in 2024. This industry is centered on using living organisms and bioprocesses for innovative drug development ...